FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 173 filers reported holding FIBROGEN INC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |